CFD RESEARCH CORPORATION — Department of Health and Human Services SBIR Phase II: NIDA

CFD RESEARCH CORPORATION — SBIR Phase II award from Department of Health and Human Services.

Amount
$1,499,740
Agency
Department of Health and Human Services · National Institutes of Health
Program / Phase
SBIR · Phase II
Topic
NIDA
NAICS
Place of performance
AL
Period

Description

This project will develop design fabricate test and demonstrate a novel SmartPlate Technology for Advanced Cell based Models STAC M The STAC M technology will be demonstrated for both current static culture and next generation cell based assays The proposed effort features a collaboration between CFD Research Corporation and Vanderbilt University and builds on several critical elements already available and demonstrated by the proposing team in particular VU developed microformulator which features a combination of low cost micropumps and valves for control and CFD developed SynVivo microfluidic devices for cell based assays The developed technologies will reduce the cost and time inefficiencies associated with the drug development process The technologies can also be used for personalized medicine applications by created an organized or disease environment on an individualized basis in an vitro environment